JP2007508359A5 - - Google Patents

Download PDF

Info

Publication number
JP2007508359A5
JP2007508359A5 JP2006534798A JP2006534798A JP2007508359A5 JP 2007508359 A5 JP2007508359 A5 JP 2007508359A5 JP 2006534798 A JP2006534798 A JP 2006534798A JP 2006534798 A JP2006534798 A JP 2006534798A JP 2007508359 A5 JP2007508359 A5 JP 2007508359A5
Authority
JP
Japan
Prior art keywords
group
branched
linear
cycloalkyl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006534798A
Other languages
English (en)
Japanese (ja)
Other versions
JP4696069B2 (ja
JP2007508359A (ja
Filing date
Publication date
Priority claimed from FR0312142A external-priority patent/FR2861073B1/fr
Application filed filed Critical
Publication of JP2007508359A publication Critical patent/JP2007508359A/ja
Publication of JP2007508359A5 publication Critical patent/JP2007508359A5/ja
Application granted granted Critical
Publication of JP4696069B2 publication Critical patent/JP4696069B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006534798A 2003-10-17 2004-10-15 N−[ヘテロアリル(ピペリジン−2−イル)メチル]ベンズアミドの誘導体、この調製方法およびこの治療法における使用 Expired - Fee Related JP4696069B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0312142 2003-10-17
FR0312142A FR2861073B1 (fr) 2003-10-17 2003-10-17 Derives de n-[heteroaryl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
PCT/FR2004/002641 WO2005037781A2 (fr) 2003-10-17 2004-10-15 Derives de n-[heteroaryl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique

Publications (3)

Publication Number Publication Date
JP2007508359A JP2007508359A (ja) 2007-04-05
JP2007508359A5 true JP2007508359A5 (cg-RX-API-DMAC7.html) 2011-03-03
JP4696069B2 JP4696069B2 (ja) 2011-06-08

Family

ID=34385235

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006534798A Expired - Fee Related JP4696069B2 (ja) 2003-10-17 2004-10-15 N−[ヘテロアリル(ピペリジン−2−イル)メチル]ベンズアミドの誘導体、この調製方法およびこの治療法における使用

Country Status (26)

Country Link
US (1) US7335670B2 (cg-RX-API-DMAC7.html)
EP (1) EP1680418B1 (cg-RX-API-DMAC7.html)
JP (1) JP4696069B2 (cg-RX-API-DMAC7.html)
KR (1) KR20060087598A (cg-RX-API-DMAC7.html)
CN (1) CN100430394C (cg-RX-API-DMAC7.html)
AT (1) ATE361923T1 (cg-RX-API-DMAC7.html)
AU (1) AU2004281215B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0415452A (cg-RX-API-DMAC7.html)
CA (1) CA2542370A1 (cg-RX-API-DMAC7.html)
CY (1) CY1106786T1 (cg-RX-API-DMAC7.html)
DE (1) DE602004006431T2 (cg-RX-API-DMAC7.html)
DK (1) DK1680418T3 (cg-RX-API-DMAC7.html)
ES (1) ES2287782T3 (cg-RX-API-DMAC7.html)
FR (1) FR2861073B1 (cg-RX-API-DMAC7.html)
HR (1) HRP20070327T3 (cg-RX-API-DMAC7.html)
IL (1) IL174941A (cg-RX-API-DMAC7.html)
MA (1) MA28097A1 (cg-RX-API-DMAC7.html)
ME (1) MEP22008A (cg-RX-API-DMAC7.html)
NO (1) NO20062151L (cg-RX-API-DMAC7.html)
NZ (1) NZ547165A (cg-RX-API-DMAC7.html)
PL (1) PL1680418T3 (cg-RX-API-DMAC7.html)
PT (1) PT1680418E (cg-RX-API-DMAC7.html)
RS (1) RS20060316A (cg-RX-API-DMAC7.html)
RU (1) RU2351596C2 (cg-RX-API-DMAC7.html)
WO (1) WO2005037781A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200603941B (cg-RX-API-DMAC7.html)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2842804B1 (fr) 2002-07-29 2004-09-03 Sanofi Synthelabo Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
FR2861074B1 (fr) * 2003-10-17 2006-04-07 Sanofi Synthelabo Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
FR2861071B1 (fr) * 2003-10-17 2006-01-06 Sanofi Synthelabo Derives de n-[phenyl(alkylpiperidin-2-yl) methyl]benzamide, leur prepartation et leur application en therapeutique
CN101072762B (zh) * 2004-12-09 2010-06-23 弗·哈夫曼-拉罗切有限公司 苯基-哌嗪甲酮衍生物
GB0428233D0 (en) * 2004-12-23 2005-01-26 Glaxo Group Ltd Compounds
PE20061156A1 (es) 2004-12-23 2006-12-16 Glaxo Group Ltd Derivados de benzamida como agentes inhibidores del transportador de glicina
WO2006067414A2 (en) * 2004-12-23 2006-06-29 Glaxo Group Limited Glycine transport inhibitors
AR057350A1 (es) * 2005-06-06 2007-11-28 Merck Sharp & Dohme Derivados de ciclohexanosulfonilo como inhibidores de glyt1 para tratar esquizofrenia. composiciones farmaceuticas
FR2906251B1 (fr) * 2006-09-22 2008-11-07 Sanofi Aventis Sa Derives de pyrrolizine, indolizine et quinolizine, leur preparation et leur application en therapeutique
ATE449062T1 (de) * 2007-02-22 2009-12-15 Indena Spa Verfahren zur herstellung von (2r,3s)-3- phenylisoserin-methylester-acetatsalz
MX2009014235A (es) 2007-08-22 2010-04-27 Abbott Gmbh & Co Kg 4-bencilaminoquinolonas, composiciones farmaceuticas que las contiene y su uso.
ES2397764T3 (es) 2008-04-01 2013-03-11 Abbott Gmbh & Co. Kg Tetrahidroisoquinolinas, composiciones farmacéuticas que las contienen, y su uso en terapia
WO2010087761A1 (en) * 2009-01-28 2010-08-05 Astrazeneca Ab 2-aza-bicyclo[2.2.2]octane compounds and uses thereof
TW201038569A (en) 2009-02-16 2010-11-01 Abbott Gmbh & Co Kg Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy
AR075442A1 (es) 2009-02-16 2011-03-30 Abbott Gmbh & Co Kg Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia
JP5618047B2 (ja) * 2010-01-29 2014-11-05 国立大学法人千葉大学 ポジトロン断層撮影法およびポジトロン放出化合物
KR101180174B1 (ko) * 2010-04-23 2012-09-05 동아제약주식회사 신규한 벤즈아미드 유도체
US8877794B2 (en) 2010-08-13 2014-11-04 Abbott Laboratories Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US8846743B2 (en) 2010-08-13 2014-09-30 Abbott Laboratories Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
US9045459B2 (en) 2010-08-13 2015-06-02 AbbVie Deutschland GmbH & Co. KG Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US9051280B2 (en) 2010-08-13 2015-06-09 AbbVie Deutschland GmbH & Co. KG Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
US8883839B2 (en) 2010-08-13 2014-11-11 Abbott Laboratories Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
US9309200B2 (en) 2011-05-12 2016-04-12 AbbVie Deutschland GmbH & Co. KG Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
WO2013020930A1 (en) 2011-08-05 2013-02-14 Abbott Gmbh & Co. Kg Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
WO2013072520A1 (en) 2011-11-18 2013-05-23 AbbVie Deutschland GmbH & Co. KG N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US9242938B2 (en) 2011-11-22 2016-01-26 Beijing Medisan Technology Co., Ltd Glycine reuptake inhibitor and use thereof
TR201806764T4 (tr) * 2011-11-29 2018-06-21 Vivozon Inc Yeni benzamid türevi ve bunun kullanımı.
US9365512B2 (en) 2012-02-13 2016-06-14 AbbVie Deutschland GmbH & Co. KG Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy
US9656955B2 (en) 2013-03-15 2017-05-23 Abbvie Inc. Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
US9650334B2 (en) 2013-03-15 2017-05-16 Abbvie Inc. Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
KR20160062164A (ko) 2013-10-17 2016-06-01 아비에 도이치란트 게엠베하 운트 콤파니 카게 아미노크로만, 아미노티오크로만 및 아미노-1,2,3,4-테트라하이드로퀴놀린 유도체, 이들을 포함하는 약제학적 조성물, 및 치료에서 이들의 용도
CA2924699A1 (en) 2013-10-17 2015-04-23 AbbVie Deutschland GmbH & Co. KG Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
US9550754B2 (en) 2014-09-11 2017-01-24 AbbVie Deutschland GmbH & Co. KG 4,5-dihydropyrazole derivatives, pharmaceutical compositions containing them, and their use in therapy
CN108218846A (zh) * 2016-12-22 2018-06-29 四川海思科制药有限公司 噻吩衍生物的新固态形式及其制备方法和用途
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201903832D0 (en) * 2019-03-20 2019-05-01 Atrogi Ab New compounds and methods
US20220233492A1 (en) * 2019-06-20 2022-07-28 Vivozon Inc. Method of preventing or treating postoperative pain
CN114478360B (zh) * 2022-02-10 2023-08-15 江苏海洋大学 一种苯甲酰胺类衍生物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254569A (en) * 1991-01-14 1993-10-19 The Du Pont Merck Pharmaceutical Company (Amidomethyl)nitrogen heterocyclic analgesics
JP3026845B2 (ja) * 1991-02-20 2000-03-27 日清製粉株式会社 ピペリジン誘導体
US6319920B1 (en) * 1998-02-27 2001-11-20 Syntex (U.S.A.) Llc 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives
CA2406652A1 (en) * 2000-04-20 2001-11-01 Nps Allelix Corp. Aminopiperidines for use as glyt-1 inhibitors
FR2838739B1 (fr) * 2002-04-19 2004-05-28 Sanofi Synthelabo Derives de n-[phenyl(piperidin-2-yl)methyl)benzamide, leur preparation et leur application en therapeutique
FR2842804B1 (fr) * 2002-07-29 2004-09-03 Sanofi Synthelabo Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique

Similar Documents

Publication Publication Date Title
JP2007508359A5 (cg-RX-API-DMAC7.html)
JP2007508362A5 (cg-RX-API-DMAC7.html)
WO2005037781A3 (fr) Derives de n-[heteroaryl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
JP2007524696A5 (cg-RX-API-DMAC7.html)
RU2011129383A (ru) Производное амина, обладающее антагостической активностью в отношении рецептора npy y5
DE602006009080D1 (de) 1-essigsäureindolderivate mit pgd2-antagonistischer wirkung
JP2005514366A5 (cg-RX-API-DMAC7.html)
JP2008526724A5 (cg-RX-API-DMAC7.html)
JP2009507896A5 (cg-RX-API-DMAC7.html)
JP2005289914A5 (cg-RX-API-DMAC7.html)
NO20080738L (no) Fremgangsmater for neurobeskyttelse
JP2005523310A5 (cg-RX-API-DMAC7.html)
JP2007519618A5 (cg-RX-API-DMAC7.html)
JP2010504286A5 (cg-RX-API-DMAC7.html)
JP2009516697A5 (cg-RX-API-DMAC7.html)
JP2010536766A5 (cg-RX-API-DMAC7.html)
JP2007523139A5 (cg-RX-API-DMAC7.html)
RU2009102535A (ru) Производные карбамидов тропана, их получение и их применение в терапии
JP2007246474A5 (cg-RX-API-DMAC7.html)
JP2005518357A5 (cg-RX-API-DMAC7.html)
JP2007519721A5 (cg-RX-API-DMAC7.html)
NO20075734L (no) Tiofenforbindelser og trombopoietin reseptoractivatorer
JP2008546770A5 (cg-RX-API-DMAC7.html)
JP2010520214A5 (cg-RX-API-DMAC7.html)
JP2007535478A5 (cg-RX-API-DMAC7.html)